VWR Acquires Purification Technologies
News Oct 08, 2015
VWR a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc. (PTI), a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.
"PTI's solvent purification expertise and process capabilities improve access to a key solvent line and enhances our portfolio of high purity products available to our customers," said Manuel Brocke-Benz, President and CEO of VWR. "Our customers in the chromatography, biochemical and agrochemical industries will benefit through VWR's ability to supply high purity Acetonitrile and other solvents in both bulk and lab scale quantities."
Based in Chester, Connecticut and founded in 1998, PTI produces high purity solvents for analytical, biotechnology and agrochemical customers internationally.
Financial details of this acquisition remain confidential.
UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based TreatmentsNews
Two grants worth more than $2.2 million have been to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.READ MORE
Chemistry Professor Awarded Prestigious Steenbock ProfessorshipNews
University of Wisconsin–Madison Professor of Chemistry Shannon Stahl has received the Steenbock Professorship in Chemical Sciences. In addition to advancing the fundamental science in this area, Stahl has been involved in numerous industrial collaborations that have led to practical applications, including target applications relevant to pharmaceutical synthesis.READ MORE
Enabling Technology in Cell-Based Therapies: Scale-Up, Scale-Out or Program In-PlaceNews
Technologies are reducing costs and changing the ways in which researchers and clinicians process and use therapeutic cells. Two new review articles detail the status of cell bioreactors in both stem cell and tissue/organ engineering applications.READ MORE